9-390512-C-T

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_203447.4(DOCK8):​c.2916C>T​(p.Thr972Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.244 in 1,613,320 control chromosomes in the GnomAD database, including 49,875 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T972T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.27 ( 5892 hom., cov: 32)
Exomes 𝑓: 0.24 ( 43983 hom. )

Consequence

DOCK8
NM_203447.4 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:11O:1

Conservation

PhyloP100: -1.31

Publications

18 publications found
Variant links:
Genes affected
DOCK8 (HGNC:19191): (dedicator of cytokinesis 8) This gene encodes a member of the DOCK180 family of guanine nucleotide exchange factors. Guanine nucleotide exchange factors interact with Rho GTPases and are components of intracellular signaling networks. Mutations in this gene result in the autosomal recessive form of the hyper-IgE syndrome. Alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Jun 2010]
DOCK8 Gene-Disease associations (from GenCC):
  • combined immunodeficiency due to DOCK8 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Orphanet, G2P, Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), ClinGen
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_203447.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.28).
BP6
Variant 9-390512-C-T is Benign according to our data. Variant chr9-390512-C-T is described in ClinVar as Benign. ClinVar VariationId is 137141.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.31 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.363 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_203447.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOCK8
NM_203447.4
MANE Select
c.2916C>Tp.Thr972Thr
synonymous
Exon 24 of 48NP_982272.2Q8NF50-1
DOCK8
NM_001193536.2
c.2712C>Tp.Thr904Thr
synonymous
Exon 23 of 47NP_001180465.1Q8NF50-3
DOCK8
NM_001190458.2
c.2616C>Tp.Thr872Thr
synonymous
Exon 22 of 46NP_001177387.1Q8NF50-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DOCK8
ENST00000432829.7
TSL:1 MANE Select
c.2916C>Tp.Thr972Thr
synonymous
Exon 24 of 48ENSP00000394888.3Q8NF50-1
DOCK8
ENST00000469391.5
TSL:1
c.2616C>Tp.Thr872Thr
synonymous
Exon 22 of 46ENSP00000419438.1Q8NF50-4
DOCK8
ENST00000382329.2
TSL:1
c.2616C>Tp.Thr872Thr
synonymous
Exon 23 of 46ENSP00000371766.2A2A369

Frequencies

GnomAD3 genomes
AF:
0.269
AC:
40843
AN:
151964
Hom.:
5886
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.368
Gnomad AMI
AF:
0.329
Gnomad AMR
AF:
0.247
Gnomad ASJ
AF:
0.189
Gnomad EAS
AF:
0.0846
Gnomad SAS
AF:
0.250
Gnomad FIN
AF:
0.191
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.244
Gnomad OTH
AF:
0.269
GnomAD2 exomes
AF:
0.228
AC:
57399
AN:
251444
AF XY:
0.230
show subpopulations
Gnomad AFR exome
AF:
0.368
Gnomad AMR exome
AF:
0.206
Gnomad ASJ exome
AF:
0.206
Gnomad EAS exome
AF:
0.0741
Gnomad FIN exome
AF:
0.189
Gnomad NFE exome
AF:
0.241
Gnomad OTH exome
AF:
0.232
GnomAD4 exome
AF:
0.241
AC:
351989
AN:
1461238
Hom.:
43983
Cov.:
35
AF XY:
0.241
AC XY:
175559
AN XY:
726970
show subpopulations
African (AFR)
AF:
0.381
AC:
12761
AN:
33454
American (AMR)
AF:
0.211
AC:
9419
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.201
AC:
5254
AN:
26134
East Asian (EAS)
AF:
0.0817
AC:
3245
AN:
39700
South Asian (SAS)
AF:
0.256
AC:
22062
AN:
86240
European-Finnish (FIN)
AF:
0.191
AC:
10180
AN:
53420
Middle Eastern (MID)
AF:
0.269
AC:
1553
AN:
5764
European-Non Finnish (NFE)
AF:
0.245
AC:
272680
AN:
1111436
Other (OTH)
AF:
0.246
AC:
14835
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14305
28610
42915
57220
71525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9238
18476
27714
36952
46190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.269
AC:
40864
AN:
152082
Hom.:
5892
Cov.:
32
AF XY:
0.263
AC XY:
19571
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.367
AC:
15233
AN:
41456
American (AMR)
AF:
0.246
AC:
3758
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.189
AC:
657
AN:
3470
East Asian (EAS)
AF:
0.0848
AC:
440
AN:
5190
South Asian (SAS)
AF:
0.251
AC:
1209
AN:
4812
European-Finnish (FIN)
AF:
0.191
AC:
2024
AN:
10590
Middle Eastern (MID)
AF:
0.276
AC:
81
AN:
294
European-Non Finnish (NFE)
AF:
0.244
AC:
16602
AN:
67972
Other (OTH)
AF:
0.266
AC:
560
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1489
2978
4467
5956
7445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.243
Hom.:
10556
Bravo
AF:
0.276
Asia WGS
AF:
0.174
AC:
609
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
8
not specified (8)
-
-
2
Combined immunodeficiency due to DOCK8 deficiency (2)
-
-
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.28
CADD
Benign
1.8
DANN
Benign
0.60
PhyloP100
-1.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=88/12
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs2297075;
hg19: chr9-390512;
COSMIC: COSV66619469;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.